Structural and biophysical insights into the role of CD4 and CD8 in T cell activation

Frontiers in Immunology

Volumn 4, Issue JUL, 2013, Pages

  Li, Yili ^a,b   Yin, Yiyuan ^c   Mariuzza, Roy A ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b Bldg 142   (United States)

^c GENENTECH INC   (United States)

Author keywords

CD4; CD8; MHC; Structure; T cell activation; T cell receptor

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CD8ALPHA ANTIGEN; DOCKING PROTEIN; HLA A ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; APOPTOSIS; CELL ACTIVATION; CELL AGGREGATION; CELL INTERACTION; CELL MATURATION; CRYSTALLIZATION; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; IMMUNOSURVEILLANCE; NONHUMAN; PROTEIN BINDING; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIALYLATION; SURFACE PLASMON RESONANCE; T LYMPHOCYTE ACTIVATION;

EID: 84883725376     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00206     Document Type: Review

References (81)

1. Janeway CA Jr. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and T cell activation. Annu Rev Immunol (1992) 10:645-54. doi:10.1146/annurev.immunol.10.1.645
2. Zamoyska R. CD4 and CD8: modulators of T-cell receptor recognition of antigen and of immune responses?. Curr Opin Immunol (1998) 10:82-7. doi:10.1016/S0952-7915(98)80036-8
3. Singer A, and Bosselut R. CD4/CD8 coreceptors in thymocyte development, selection, and lineage commitment: analysis of the CD4/CD8 lineage decision. Adv Immunol (2004) 83:91-131. doi:10.1016/S0065-2776(04)83003-7
4. Laugel B, van den Berg HA, Gostick E, Cole DK, Wooldridge L, Boulter J, et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem (2007) 282:23799-810. doi:10.1074/jbc. M700976200
5. Irvine DJ, Purbhoo MA, Krogsgaard M, Davis MM. Direct observation of ligand recognition by T cells. Nature (2002) 419:845-9. doi:10.1038/nature01076
6. Holler PD, Kranz DM. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity (2003) 18:255-64. doi:10.1016/S1074-7613(03)00019-0
7. Li QJ, Dinner AR, Qi S, Irvine DJ, Huppa JB, Davis MM, et al. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nat Immunol (2004) 5:791-9. doi:10.1038/ni1095
8. Artyomov MN, Lis M, Devadas S, Davis MM, Chakraborty AK. CD4 and CD8 binding to MHC molecules primarily acts to enhance Lck delivery. Proc Natl Acad Sci U S A (2010) 107:16916-21. doi:10.1073/pnas.1010568107
9. Jiang N, Huang J, Edwards LJ, Liu B, Zhang Y, Beal CD, et al. Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination. Immunity (2011) 34:13-23. doi:10.1016/j.immuni.2010.12.017
10. van der Merwe PA, Cordoba SP. Late arrival: recruiting coreceptors to the T cell receptor complex. Immunity (2011) 34:1-3. doi:10.1016/j.immuni.2011.01.001
11. Van Laethem F, Tikhonova AN, Singer A. MHC restriction is imposed on a diverse T cell repertoire by CD4 and CD8 co-receptors during thymic selection. Trends Immunol (2012) 33:437-41. doi:10.1016/j.it.2012.05.006
12. Van Laethem F, Sarafova SD, Park JH, Tai X, Pobezinsky L, Guinter TI, et al. Deletion of CD4 and CD8 coreceptors permits generation of αβT cells that recognize antigens independently of the MHC. Immunity (2007) 27:735-50. doi:10.1016/j.immuni.2007.10.007
13. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, et al. αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity (2012) 36:79-81. doi:10.1016/j.immuni.2011.11.013
14. Devine L, Kieffer LJ, Aitken V, Kavathas PB. Human CD8β, but not mouse CD8β, can be expressed in the absence of CD8β as a αβ homodimer. J Immunol (2000) 164:833-8.
15. Cheroutre H, Lambolez F. Doubting the TCR coreceptor function of CD8αββ. Immunity (2008) 28:149-56. doi:10.1016/j.immuni.2008.01.005
16. Fung-Leung WP, Schilham MW, Rahemtulla A, Kündig TM, Vollenweider M, Potter J, et al. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell (1991) 65:443-9. doi:10.1016/0092-8674(91)90462-8
17. Crooks ME, Littman DR. Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 β chain. Immunity (1994) 1:277-85. doi:10.1016/1074-7613(94)90079-5
18. Nakayama K, Negishi I, Kuida K, Louie MC, Kanagawa O, Nakauchi H, et al. Requirement for CD8 β chain in positive selection of CD8-lineage T cells. Science (1994) 263:1131-3. doi:10.1126/science.8108731
19. Moebius U, Kober G, Griscelli AL, Hercend T, Meuer SC. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur J Immunol (1991) 21:1793-800. doi:10.1002/eji.1830210803
20. Grebe KM, Clarke RL, Potter TA. Ligation of CD8 leads to apoptosis of thymocytes that have not undergone positive selection. Proc Natl Acad Sci U S A (2004) 101:10410-5. doi:10.1073/pnas.0402079101
21. Yachi PP, Ampudia J, Zal T, Gascoigne NR. Altered peptide ligands induce delayed CD8-T cell receptor interaction - a role for CD8 in distinguishing antigen quality. Immunity (2006) 25:203-11. doi:10.1016/j.immuni.2006.05.015
22. Garcia KC, Scott CA, Brunmark A, Carbone FR, Peterson PA, Wilson IA, et al. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature (1996) 384:577-81. doi:10.1038/384577a0
23. Wang R, Natarajan K, Margulies DH. Structural basis of the CD8 αβ/MHC class I interaction: focused recognition orients CD8 β to a T cell proximal position. J Immunol (2009) 183:2554-64. doi:10.4049/jimmunol.0901276
24. Wyer JR, Willcox BE, Gao GF, Gerth UC, Davis SJ, Bell JI, et al. T cell receptor and coreceptor CD8 αβ bind peptide-MHC independently and with distinct kinetics. Immunity (1999) 10:219-25. doi:10.1016/S1074-7613(00)80022-9
25. Gao GF, Willcox BE, Wyer JR, Boulter JM, O'Callaghan CA, Maenaka K, et al. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8αβ. J Biol Chem (2000) 275:15232-8. doi:10.1074/jbc. M909946199
26. Cole DK, Dunn SM, Sami M, Boulter JM, Jakobsen BK, Sewell AK. T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding. Mol Immunol (2008) 45:2700-9. doi:10.1016/j.molimm.2007.12.009
27. Huang J, Edwards LJ, Evavold BD, Zhu C. Kinetics of MHC-CD8 interaction at the T cell membrane. J Immunol (2007) 179:7653-62.
28. Zhu C, Jiang N, Huang J, Zarnitsyna VI, Evavold BD. Insights from in situ analysis of TCR-pMHC recognition: response of an interaction network. Immunol Rev (2013) 251:49-64. doi:10.1111/imr.12016
29. Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, Stuart DI, et al. Crystal structure of the complex between human CD8αβ and HLA-A2. Nature (1997) 387:630-4. doi:10.1038/42523
30. Shi Y, Qi J, Iwamoto A, Gao GF. Plasticity of human CD8αβ binding to peptide-HLA-A*2402. Mol Immunol (2011) 48:2198-202. doi:10.1016/j.molimm.2011.05.009
31. Kern PS, Teng MK, Smolyar A, Liu JH, Liu J, Hussey RE, et al. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8αβ ectodomain fragment in complex with H-2Kb. Immunity (1998) 9:519-30. doi:10.1016/S1074-7613(00)80635-4
32. Casabó LG, Mamalaki C, Kioussis D, Zamoyska R. T cell activation results in physical modification of the mouse CD8β chain. J Immunol (1994) 152:397-404.
33. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science (2001) 291:2370-6. doi:10.1126/science.291.5512.2370
34. Moody AM, Chui D, Reche PA, Priatel JJ, Marth JD, Reinherz EL. Developmentally regulated glycosylation of the CD8αβ coreceptor stalk modulates ligand binding. Cell (2001) 107:501-12. doi:10.1016/S0092-8674(01)00577-3
35. Daniels MA, Devine L, Miller JD, Moser JM, Lukacher AE, Altman JD, et al. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity (2001) 15:1051-61. doi:10.1016/S1074-7613(01)00252-7
36. Merry AH, Gilbert RJ, Shore DA, Royle L, Miroshnychenko O, Vuong M, et al. O-glycan sialylation and the structure of the stalk-like region of the T cell coreceptor CD8. J Biol Chem (2003) 278:27119-28. doi:10.1074/jbc. M213056200
37. Santos SG, Powis SJ, Arosa FA. Misfolding of major histocompatibility complex class I molecules in activated T cells allows cis-interactions with receptors and signaling molecules and is associated with tyrosine phosphorylation. J Biol Chem (2004) 279:53062-70. doi:10.1074/jbc. M408794200
38. Back J, Malchiodi EL, Cho S, Scarpellino L, Schneider P, Kerzic MC, et al. Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. Immunity (2009) 31:598-608. doi:10.1016/j.immuni.2009.07.007
39. Hartmann J, Tran TV, Kaudeer J, Oberle K, Herrmann J, Quagliano I, et al. The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding. J Biol Chem (2012) 287:31527-39. doi:10.1074/jbc. M111.304238
40. Shogren R, Gerken TA, Jentoft N. Role of glycosylation on the conformation and chain dimensions of O-linked glycoproteins: light scattering studies of ovine submaxillary mucin. Biochemistry (1989) 28:5525-36. doi:10.1021/bi00439a029
41. Gerken TA, Butenhof JK, Shogren R. Effects of glycosylation on the conformation and dynamics of O-linked glycoproteins: carbon-13 NMR studies of ovine submaxillary mucin. Biochemistry (1989) 28:5536-43. doi:10.1021/bi00439a030
42. Shore DA, Wilson IA, Dwek RA, Rudd PM. Glycosylation and the function of the T cell co-receptor CD8. Adv Exp Med Biol (2005) 564:71-84. doi:10.1007/0-387-25515-X_12
43. Davis SJ, Ikemizu S, Evans EJ, Fugger L, Bakker TR, van der Merwe PA. The nature of molecular recognition by T cells. Nat Immunol (2003) 4:217-24. doi:10.1038/ni0303-217
44. Cole DK, Pumphrey NJ, Boulter JM, Sami M, Bell JI, Gostick E, et al. Human TCR-binding affinity is governed by MHC class restriction. J Immunol (2007) 178:5727-34.
45. Xiong Y, Kern P, Chang H, Reinherz E. T cell receptor binding to a pMHCII ligand is kinetically distinct from and independent of CD4. J Biol Chem (2001) 276:5659-67. doi:10.1074/jbc. M009580200
46. Robinson J, Mistry K, McWilloam H, Lopez R, Parham P, Marsh SGE The IMGT/HLA database. Nucleic Acids Res (2011) 39D1171-6. doi:10.1093/nar/gkq998
47. Wang JH, Meijers R, Xiong Y, Liu JH, Sakihama T, Zhang R, et al. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci U S A (2001) 98:10799-804. doi:10.1073/pnas.191124098
48. Wang XX, Li Y, Yin Y, Mo M, Wang Q, Gao W, et al. Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex. Proc Natl Acad Sci U S A (2011) 108:15960-5. doi:10.1073/pnas.1109438108
49. Yin Y, Wang XX, Mariuzza RA. Crystal structure of a complete ternary complex of T-cell receptor, peptide-MHC, and CD4. Proc Natl Acad Sci U S A (2012) 109:5405-10. doi:10.1073/pnas.1118801109
50. Gai SA, Wittrup KD. Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol (2007) 17:467-73. doi:10.1016/j.sbi.2007.08.012
51. Yin Y, Li Y, Kerzic MC, Martin R, Mariuzza RA. Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection. EMBO J (2011) 30:1137-48. doi:10.1038/emboj.2011.21
52. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 24:419-66. doi:10.1146/annurev.immunol.23.021704.115658
53. Marrack P, Scott-Browne JP, Dai S, Gapin L, Kappler JW. Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu Rev Immunol (2008) 26:171-203. doi:10.1146/annurev.immunol.26.021607.090421
54. Wu H, Kwong PD, Hendrickson WA. Dimeric association and segmental variability in the structure of human CD4. Nature (1997) 387:527-30. doi:10.1038/387527a0
55. van der Merwe PA, Dushek O. Mechanisms of T cell receptor triggering. Nat Rev Immunol (2010) 11:47-55. doi:10.1038/nri2887
56. Kuhns MS, Davis MM. Disruption of extracellular interactions impairs T cell receptor-CD3 complex stability and signaling. Immunity (2007) 26:357-69. doi:10.1016/j.immuni.2007.01.015
57. Kuhns MS, Girvin AT, Klein LO, Chen R, Jensen KD, Newell EW, et al. Evidence for a functional sidedness to the αβ TCR. Proc Natl Acad Sci U S A (2010) 107:5094-9. doi:10.1073/pnas.1000925107
58. Fernandes RA, Shore DA, Vuong MT, Yu C, Zhu X, Pereira-Lopes S, et al. The T-cell receptor is a structure capable of initiating signaling in the absence of large conformational rearrangements. J Biol Chem (2012) 287:13324-35. doi:10.1074/jbc. M111.332783
59. Call ME, Pyrdol J, Wiedmann M, Wucherpfennig KW. The organizing principle in the formation of the T cell receptor-CD3 complex. Cell (2002) 111:967-79. doi:10.1016/S0092-8674(02)01194-7
60. Xu C, Gagnon E, Call ME, Schnell JR, Schwieters CD, Carman CV, et al. Regulation of T cell receptor activation by dynamic membrane binding of the CD3β cytoplasmic tyrosine-based motif. Cell (2008) 135:702-13. doi:10.1016/j.cell.2008.09.044
61. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, et al. Three-dimensional structure of the human class II histocompatibility antigen HLADR1. Nature (1993) 364:33-9. doi:10.1038/364033a0
62. Moldovan MC, Sabbagh L, Breton G, Sékaly RP, Krummel MF. Triggering of T cell activation via CD4 dimers. J Immunol (2006) 176:5438-45.
63. Ghosh P, Amaya M, Mellins E, Wiley DC. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature (1995) 378:457-62. doi:10.1038/378457a0
64. Kuhns MS, Badgandi HB. Piecing together the family portrait of TCR-CD3 complexes. Immunol Rev (2012) 250:120-43. doi:10.1111/imr.12000
65. Wang JH, Reinherz EL. Revisiting the putative TCR Cβ dimerization model through structural analysis. Front Immunol (2013) 4:16. doi:10.3389/fimmu.2013.00016
66. Kim ST, Takeuchi K, Sun ZY, Touma M, Castro CE, Fahmy A, et al. The αβ T cell receptor is an anisotropic mechanosensor. J Biol Chem (2009) 284:31028-37. doi:10.1074/jbc. M109.052712
67. Li YC, Chen BM, Wu PC, Cheng TL, Kao LS, Tao MH, et al. Cutting edge: mechanical forces acting on T cells immobilized via the TCR complex can trigger TCR signaling. J Immunol (2010) 184:5959-63. doi:10.4049/jimmunol.0900775
68. Judokusumo E, Tabdanov E, Kumari S, Dustin ML, Kam LC. Mechanosensing in T lymphocyte activation. Biophys J (2012) 102L5-7. doi:10.1016/j.bpj.2011.12.011
69. Garcia KC, Adams JJ, Feng D, Ely LK. The molecular basis of TCR germline bias for MHC is surprisingly simple. Nat Immunol (2009) 10:143-7. doi:10.1038/ni.f.219
70. Scott-Browne JP, White J, Kappler JW, Gapin L, Marrack P. Germline-encoded amino acids in the αβ T-cell receptor control thymic selection. Nature (2009) 458:1043-6. doi:10.1038/nature07812
71. Adams JJ, Narayanan S, Liu B, Birnbaum ME, Kruse AC, Bowerman NA, et al. T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. Immunity (2011) 35:681-93. doi:10.1016/j.immuni.2011.09.013
72. Garcia KC. Reconciling views on T cell receptor germline bias for MHC. Trends Immunol (2012) 33:429-36. doi:10.1016/j.it.2012.05.005
73. Deng L, Langley RJ, Wang Q, Topalian SL, Mariuzza RA. Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vβ CDR3. Proc Natl Acad Sci U S A (2012) 109:14960-5. doi:10.1073/pnas.1207186109
74. Buslepp J, Wang H, Biddison WE, Appella E, Collins EJ. A correlation between TCR Vβ docking on MHC and CD8 dependence: implications for T cell selection. Immunity (2003) 19:595-606. doi:10.1016/S1074-7613(03)00269-3
75. Mazza C, Malissen B. What guides MHC-restricted TCR recognition?. Semin Immunol (2007) 19:225-35. doi:10.1016/j.smim.2007.03.003
76. Hahn M, Nicholson MJ, Pyrdol J, Wucherpfennig KW. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol (2005) 6:490-6. doi:10.1038/ni1187
77. Boggon TJ, Eck MJ. Structure and regulation of Src family kinases. Oncogene (2004) 23:7918-27. doi:10.1038/sj.onc.1208081
78. Sigalov AB, Aivazian DA, Uversky VN, Stern LJ. Lipid-binding activity of intrinsically unstructured cytoplasmic domains of multichain immune recognition receptor signaling subunits. Biochemistry (2006) 45:15731-9. doi:10.1021/bi061108f
79. Rettig LL, McNeill L, Sarner N, Guillaume P, Luescher I, Tolaini M, et al. An essential role for the stalk region of CD8 β in the coreceptor function of CD8. J Immunol (2009) 182:121-9.
80. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature (2005) 435:590-7. doi:10.1038/nature03724
81. Wucherpfennig KW, Call MJ, Deng L, Mariuzza RA. Structural alterations in peptide-MHC recognition by self-reactive T cell receptors. Curr Opin Immunol (2009) 21:590-5. doi:10.1016/j.coi.2009.07.00